These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1247972)

  • 1. Current status of research in detection and diagnosis.
    Berlin NI
    Cancer; 1976 Jan; 37(1 suppl):417-20. PubMed ID: 1247972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of research in cancer diagnosis.
    Berlin NI
    Mayo Clin Proc; 1975 May; 50(5):249-54. PubMed ID: 1092925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
    Lawson HW; Henson R; Bobo JK; Kaeser MK
    MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programs and plans of the National Cancer Institute for the research and application of research methods in diagnostics to the diagnosis of cancer.
    Berlin NI
    Cancer; 1974 Jun; 33(6):1705-11. PubMed ID: 4835161
    [No Abstract]   [Full Text] [Related]  

  • 5. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer screening practices from National Health Interview Surveys: past, present, and future.
    Hiatt RA; Klabunde C; Breen N; Swan J; Ballard-Barbash R
    J Natl Cancer Inst; 2002 Dec; 94(24):1837-46. PubMed ID: 12488477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Cancer at Baseline Screening in the National Cancer Institute Li-Fraumeni Syndrome Cohort.
    Mai PL; Khincha PP; Loud JT; DeCastro RM; Bremer RC; Peters JA; Liu CY; Bluemke DA; Malayeri AA; Savage SA
    JAMA Oncol; 2017 Dec; 3(12):1640-1645. PubMed ID: 28772286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint National Cancer Institute-Food and Drug Administration workshop on research strategies, study designs, and statistical approaches to biomarker validation for cancer diagnosis and detection.
    Maruvada P; Srivastava S
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1078-82. PubMed ID: 16775163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. History, development and future of cancer screening in Australia.
    Olver IN; Roder D
    Public Health Res Pract; 2017 Jul; 27(3):. PubMed ID: 28765858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
    Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
    Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
    Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
    J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of health status of a population underwent routine medical check up at the high risk screening clinic in National Cancer Institute.
    Sangrajrang S; Chokvanitphong V; Sumetchotimaytha W; Khuhaprema T
    Asian Pac J Cancer Prev; 2012; 13(11):5759-62. PubMed ID: 23317252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of the U.S. Preventive Services Task Force guidelines on cancer screening: perspective from the National Cancer Institute.
    Smart CR
    J Gen Intern Med; 1990; 5(5 Suppl):S28-33. PubMed ID: 2231061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of mammography, Pap test and prostate examination by body mass index during the developmental period of cancer screening in Estonia.
    Tekkel M; Veideman T; Rahu M
    Public Health; 2011 Oct; 125(10):697-703. PubMed ID: 21907366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digital mammography and related technologies: a perspective from the National Cancer Institute.
    Shtern F
    Radiology; 1992 Jun; 183(3):629-30. PubMed ID: 1584908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of screening mammography in the United States and the United kingdom.
    Smith-Bindman R; Chu PW; Miglioretti DL; Sickles EA; Blanks R; Ballard-Barbash R; Bobo JK; Lee NC; Wallis MG; Patnick J; Kerlikowske K
    JAMA; 2003 Oct; 290(16):2129-37. PubMed ID: 14570948
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.